ALEXANDRE DE MELO KAWASSAKI
Projetos de Pesquisa
Unidades Organizacionais
Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas, Faculdade de Medicina - Médico
3 resultados
Resultados de Busca
Agora exibindo 1 - 3 de 3
- Clinical and epidemiological profile of patients with definite ocular sarcoidosis at a Brazilian referral center(2022) FERRACIOLI-ODA, Eduardo; KAWASSAKI, Alexandre de Melo; ARIMURA, Fabio Eiji; KAIRALLA, Ronaldo Adib; HIRATA, Carlos Eduardo; YAMAMOTO, Joyce Hisae
- Clinical standards for diagnosis, treatment and prevention of post-COVID-19 lung disease(2023) VISCA, D.; CENTIS, R.; PONTALI, E.; ZAMPOGNA, E.; RUSSELL, A. -M.; MIGLIORI, G. B.; ANDREJAK, C.; ARO, M.; BAYRAM, H.; BERKANI, K.; BRUCHFELD, J.; CHAKAYA, J. M.; CHOROSTOWSKA-WYNIMKO, J.; CRESTANI, B.; DALCOLMO, M. P.; D'AMBROSIO, L.; DINH-XUAN, A-T.; DUONG-QUY, S.; FERNANDES, C.; GARCIA-GARCIA, J. -M.; KAWASSAKI, A. de Melo; CARROZZI, L.; MARTINEZ-GARCIA, M. A.; MARTINS, P. Carreiro; MIRSAEIDI, M.; MOHAMMAD, Y.; NAIDOO, R. N.; NEUPARTH, N.; SESE, L.; SILVA, D. R.; SOLOVIC, I.; SOORONBAEV, T. M.; SPANEVELLO, A.; SVERZELLATI, N.; TANNO, L.; TIBERI, S.; VASANKARI, T.; VASARMIDI, E.; VITACCA, M.; ANNESI-MAESANO, I.BACKGROUND: The aim of these clinical standards is to provide guidance on 'best practice' care for the diagnosis, treatment and prevention of post-COVID-19 lung disease.METHODS: A panel of international experts representing scientific societies, associations and groups active in post-COVID-19 lung disease was identified; 45 completed a Delphi process. A 5-point Likert scale indicated level of agreement with the draft standards. The final version was approved by consensus (with 100% agreement).RESULTS: Four clinical standards were agreed for patients with a previous history of COVID-19: Standard 1, Patients with sequelae not explained by an alternative diagnosis should be evaluated for possible post-COVID-19 lung disease; Standard 2, Patients with lung function impairment, reduced exercise tolerance, reduced quality of life (QoL) or other relevant signs or ongoing symptoms >= 4 weeks after the onset of first symptoms should be evaluated for treatment and pulmonary rehabilitation (PR); Standard 3, The PR programme should be based on feasibility, effectiveness and cost-effectiveness criteria, organised according to local health services and tailored to an individual patient's needs; and Standard 4, Each patient undergoing and completing PR should be evaluated to determine its effectiveness and have access to a counselling/health education session.CONCLUSION: This is the first consensus-based set of clinical standards for the diagnosis, treatment and prevention of post-COVID-19 lung disease. Our aim is to improve patient care and QoL by guiding clinicians, programme managers and public health officers in planning and implementing a PR programme to manage postCOVID-19 lung disease.
- Twenty-year-old patient with polyarthritis since childhood showing cysts and ground glass attenuation on HRCT(2024) FAGUNDES, Marilia da Cruz; BIANCO, Thais; NUNES, Daniella Porfirio; OSTROSKI, Tayza Katelline Danilau; BRIDI, Guilherme das Posses; KAWASSAKI, Alexandre Melo; BARBAS, Carmen Silvia Valente; MENDONCA, Leonardo Oliveira; BARROS, Samar Freschi; KALIL, Jorge; SHUM, Anthony K.; ESCUISSATO, Dante Luiz